Chimeric Antigen Receptor Treatment Targeting CD70 (SEVENTY)

Clinical trial NCT06345027 · NOT_YET_RECRUITING

Trial details

NCT number: NCT06345027
Sponsor: Baylor College of Medicine
Status: NOT_YET_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Leukemia, Myeloid, Acute Leukemia, B-cell Leukemia, T-Cell

Start date: 2026-02-01
Primary completion: 2027-05-01
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.